YP1 Intrinsic Valuation and Fundamental Analysis - Immutep Ltd - Alpha Spread

Watchlist Manager

Watchlist

Price: 0.011 EUR -8.33% Market Closed

Market Cap: €16.2m

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Immutep Ltd.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Immutep Does

Biotechnology Health Care

Immutep Ltd is a biotechnology company that develops immunotherapy medicines for cancer and autoimmune disease. Its main work is centered on drugs that try to help the immune system work better against tumors or calm it down when the immune system is overactive. The company does not sell consumer products; it sells science, drug candidates, and rights to those programs.

Headquarters: Australia AU
Employees: 31
IPO date: Jun 23, 1988

Read the full company overview

How Immutep makes money

Immunotherapy drugs

Immutep develops cancer and autoimmune medicines based on LAG-3 biology. It runs laboratory research, clinical trials, and partner programs to turn its drug candidates into approved treatments.

Customers: Patients and doctors would use the medicines if approved. During development, the main buyers are pharmaceutical partners and research collaborators that license the technology or help fund development.
Revenue Model: The company makes money through research and development collaboration payments, licensing deals, milestone payments, and future product sales or royalties if its medicines reach market.

View Company Overview

Jun 2016 Dec 2016 Jun 2017 Dec 2017 Jun 2018 Dec 2018 Jun 2019 Dec 2019 Jun 2020 Dec 2020 Jun 2021 Dec 2021 Jun 2022 Dec 2022 Jun 2023 Dec 2023 Jun 2024 Dec 2024 Jun 2025 Dec 2025 Jun 2026

Wall St Price Targets

Capital Returns

Competitive Landscape

Continue YP1 Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 362,700+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.